{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9(5)"],"submitter":["De Salvo M"],"pubmed_abstract":["Rhabdomyosarcoma (RMS) is a pediatric myogenic-derived soft tissue sarcoma that includes two major histopathological subtypes: embryonal and alveolar. The majority of alveolar RMS expresses PAX3-FOXO1 fusion oncoprotein, associated with the worst prognosis. RMS cells show myogenic markers expression but are unable to terminally differentiate. The Notch signaling pathway is a master player during myogenesis, with Notch1 activation sustaining myoblast expansion and Notch3 activation inhibiting myoblast fusion and differentiation. Accordingly, Notch1 signaling is up-regulated and activated in embryonal RMS samples and supports the proliferation of tumor cells. However, it is unable to control their differentiation properties. We previously reported that Notch3 is activated in RMS cell lines, "],"journal":["PloS one"],"pagination":["e96238"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4010457"],"repository":["biostudies-literature"],"pubmed_title":["Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells."],"pmcid":["PMC4010457"],"pubmed_authors":["Miele L","Citti A","Rota R","Pannuti A","Boldrini R","Adesso L","Locatelli F","Ciarapica R","Milano GM","Inserra A","Stifani S","Vella S","Ferrari A","Locatelli M","Alaggio R","Cacchione A","Bisogno G","Screpanti I","Collini P","Rosolen A","De Salvo M","Raimondi L","Verginelli F"],"additional_accession":[]},"is_claimable":false,"name":"Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.","description":"Rhabdomyosarcoma (RMS) is a pediatric myogenic-derived soft tissue sarcoma that includes two major histopathological subtypes: embryonal and alveolar. The majority of alveolar RMS expresses PAX3-FOXO1 fusion oncoprotein, associated with the worst prognosis. RMS cells show myogenic markers expression but are unable to terminally differentiate. The Notch signaling pathway is a master player during myogenesis, with Notch1 activation sustaining myoblast expansion and Notch3 activation inhibiting myoblast fusion and differentiation. Accordingly, Notch1 signaling is up-regulated and activated in embryonal RMS samples and supports the proliferation of tumor cells. However, it is unable to control their differentiation properties. We previously reported that Notch3 is activated in RMS cell lines, ","dates":{"release":"2014-01-01T00:00:00Z","publication":"2014","modification":"2025-04-19T02:41:37.481Z","creation":"2019-03-26T23:24:38Z"},"accession":"S-EPMC4010457","cross_references":{"pubmed":["24797362"],"doi":["10.1371/journal.pone.0096238"]}}